← Home / Merck & Co., Inc. (MRK)
Stock Analysis
Merck & Co., Inc. (MRK)
MRK
MRK · Healthcare • Pharma
129.79 -0.44%
Track MRK in your personal workspace Monitor performance, SPY relative strength and WOI View from your watchlist.
Alert me when MRK price is:
52W Range Position
96%
LOWMIDHIGH
Trend
Constructive
Momentum
Neutral
Updated: 2026-07-31 11:45 UTC
WOI Investment Thesis
Constructive
Confirmation improves above 131.82. Holding above 123.55 keeps the current thesis intact.
⚖️
Fundamentals
Improving / Negative
Price Structure
Constructive
Momentum
Neutral
×
Breakout Confirmation
Pending
Risk Level
Moderate
Analysis Scope
1Y Daily
Key Decision Levels
Hold Above
Structure remains valid above support.
123.55
Break Above
Confirmation improves above resistance.
131.82
🎯
Next Objective
Pattern-derived target if setup continues.
×
Thesis Break
Scenario weakens below invalidation.
Below 123.55
Recent Company Events
SEC VERIFIED
Latest material filings
MAY
22
$
Debt Financing
HIGH
MRK debt financing update
(the “Company”) closed an underwritten public offering of $500,000,000 aggregate principal amount of Floating Rate Notes due 2028 (the “Floating Rate Notes”), $1,000,000,000 aggregate principal amount of 4.300% Notes due 2028 (the “2028 Notes”), $500,000,000 aggregate principal amount of 4.650% Notes due 2031 (the “...
8-K Filing SEC EDGAR
APR
30
Financial Results
HIGH
Co., Inc., Rahway, N.J., USA Announces First-Quarter 2026 Financial Results; Highlights Significant Regulatory Approvals and Clinical
Merck & Co., Inc., Rahway, N.J., USA (NYSE: MRK), known as MSD outside the United States and Canada, today announced financial results for the first quarter of 2026.
8-K Filing SEC EDGAR
What's Driving MRK?
📈 Technical recovery is improving
Momentum is Neutral. Watch 131.82 for confirmation and 123.55 for structure risk.
💼 Business quality remains relevant
Fundamentals remain relevant. Check growth, profitability, cash flow and balance sheet quality.
⚠️ Key risk remains
Below 123.55
Full Analysis Workspace
Technical Signal
Waiting for Confirmation
No confirmed breakout yet. Watch the next level and momentum behavior.
Pattern
Triangle Compression / SYM / DOWN
State
Forming
Compression
24%
RSI(14)
57.8
How to read this setup
The nearest decision zone is framed by support around 123.55 and resistance near 130.90. A cleaner push through resistance would improve continuation odds, while a loss of support would weaken the current thesis.
Price Chart
MRK — 1D Chart
Open Full Workspace
Valuation Snapshot (TTM)
Full valuation · Ratios use trailing twelve months
Updated 2026-07-30
Fair
Fair valuation
The earnings multiple is in a moderate range.
Market Cap
$320.8B
Company size
EV
$335.9B
Debt-adjusted value
P/E
35.9
Premium
P/S
4.9
Balanced
P/B
7.0
Balanced
EV/Sales
5.1
Balanced
P/FCF
22.7
Reasonable
FCF Yield
4.40%
Cash return
Source: SEC TTM data via WOI valuation cache Not financial advice
Business Lens
Long-term structure remains supportive
Financial quality is mixed, with cash flow or balance sheet items requiring closer monitoring.
Revenue Growth
Improving
Profitability
Negative
Cash Flow
Healthy
Balance Sheet
Manageable
💵 Revenue
16.29B
↗ Improving
📈 Net Income
-4.24B
↘ Negative
🧮 EPS (Basic)
-1.72
↘ Negative
Merck & Co., Inc.
Healthcare • Pharma